That's a WTO requirement that 146 countries signed on to, that they needed to notify the WTO that they had insufficient manufacturing to produce these kinds of drugs. The suggestion was made that Canada should go to the WTO and change this agreement of 146 countries. Those negotiations are tough enough to do in the first place. I don't see that necessarily happening. But that's a WTO requirement, and Canada has respected those WTO decisions in terms of drafting the legislation for this.
The only thing I would add is, in all fairness, everybody had a chance to negotiate with the Canadian government for, I think Brian said, 15 months, but everybody was at the table, everybody knew what they were talking about, and everybody tried to simplify the process in the best interest of trying to get products shipped to Africa.
I think one question that wasn't answered was whether there was that much of a supply here in Canada, through the generic industry, many of whom do not have manufacturing here. There are a couple of major companies—Apotex is one—that could actually participate in this bill, but I think there was an assumption that we had this big generic industry that was going to jump on this and participate, and I don't think that's possible.